Enliven Therapeutics
ELVN
#3857
Rank
NZ$6.25 B
Marketcap
NZ$87.55
Share price
2.17%
Change (1 day)
170.43%
Change (1 year)

Enliven Therapeutics (ELVN) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : NZ$20.18 Million

According to Enliven Therapeutics's latest financial reports the company's total liabilities are NZ$20.18 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enliven Therapeutics - Total liabilities on balance sheet (from 2021 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$28.6 M1.37%
2024-12-31NZ$28.21 M-31.26%
2023-12-31NZ$41.05 M-83.72%
2022-12-31NZ$0.25 B10.27%
2021-12-31NZ$0.22 B9.06%
2020-12-31NZ$0.20 B